Health knowledge made personal
Join this community!
› Share page:
Search posts:

2010 - a Significant Year for those affected by Multiple Sclerosis

Posted Dec 13 2010 12:00am

1) MS Views and News - launches it's first educational seminar in February - a Spanish language program, the first for the Miami area
2) Then MS Views and News held educational programs in each of the following months.
3) In November, MS Views and News - Held it's first MS Symposium and a first for Miami to have had a function of that caliber
4) First ORAL Medication is FDA approved for Relapse Remitting Multiple Sclerosis. The U.S. Food and Drug Administration has approved fingolimod capsules (Gilenya,™ Novartis International AG) for reducing the frequency of clinical relapses and delaying the accumulation of physical disability in relapsing forms of MS, making it the first oral disease-modifying therapy for the treatment of multiple sclerosis. According to Novartis, the drug will be available for prescription in coming weeks.
5The Liberation Treatment - is being persued as the public wants more information on the understanding of CCSVI (Chronic Cerebro Spinal Venous Insufficency). New Studies will carry out significant steps needed to confirm the phenomenon originally described by Dr. Paolo Zamboni and resolve the questions raised by him and others as to whether CCSVI is a cause of MS or related to MS in some other manner.
6) Aside from our MS blog and website , we can also be found on Facebook and You Tube as shown below  
7) MS Views and News - will continue to provide educational information and resources for those affected by MS, into 2011 and beyond.
Happy Holidays!!
Sincere Regards,
Stuart Schlossman
Stuart Schlossman
President - MS Views and News

****************************************************************If you find our information valuable, please donate by clicking here   -- all contributions are tax deductible --****************************************************************
"Providing You with 'MS Views and News', is what we do"
Keep Informed and up-to-date with information concerning
 Multiple Sclerosis when registered at
the MS Views and News   website.
Disclaimer:  'MS Views and News' (MSVN), does not endorse any products or services  ****************************************************************
Post a comment
Write a comment:

Related Searches